Oncology & Cancer

Sorafenib, sunitinib may pose cardiovascular risk

(HealthDay)—Older kidney cancer patients treated with sorafenib or sunitinib may face an increased risk of cardiovascular adverse events, according to a study published online Oct. 6 in Cancer.

Cardiology

Childhood trauma may boost heart disease risk for a lifetime

MONDAY, Sept. 28, 2015 (HealthDay News) —Experiencing high levels of mental stress at any point in life—even if only in childhood—may raise the risk for heart disease, stroke or diabetes in adulthood, a new study suggests.

Cardiology

Harms from unnecessary abx extend beyond resistance

(HealthDay)—Use of antibiotics in patients with heart failure exacerbation in the absence of compelling evidence of infection is unnecessary and potentially harmful, according to teachable moment piece published online ...

page 21 from 37